Sculptra vs Radiesse: PLLA vs CaHA biostimulators compared

Sculptra and Radiesse are the two most widely used biostimulatory fillers in the United States. Both encourage the body to produce its own collagen rather than simply occupying space beneath the skin. But they are built from fundamentally different materials — poly-L-lactic acid (PLLA) versus calcium hydroxylapatite (CaHA) — and those differences affect everything from onset time to session count, treatment areas, reversibility, and longevity.

This comparison covers what each product is, how their mechanisms differ, what the FDA has approved them for, how they perform in practice, and which patients tend to be better candidates for each.

What each product is

Sculptra (poly-L-lactic acid / PLLA)

Sculptra is an injectable implant containing microparticles of poly-L-lactic acid (PLLA), carboxymethylcellulose, non-pyrogenic mannitol, and sterile water. PLLA is a biodegradable synthetic polymer from the alpha-hydroxy-acid family, used in dissolvable sutures for decades.

Sculptra is supplied in 367.5 mg vials that must be reconstituted with 5 mL of sterile water before injection, forming a suspension. Lidocaine can be added to reduce discomfort.

FDA approval history:

• August 3, 2004 (PMA P030050): Approved for restoration and/or correction of facial fat loss (lipoatrophy) in people with HIV.
• July 28, 2009 (P030050/S002): Expanded to immunocompetent patients for correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles.
• April 25, 2023 (P030050/S039): Further expanded to include correction of fine lines and wrinkles in the cheek region for immunocompetent patients. FDA labeling notes results may last up to 24 months.

Radiesse (calcium hydroxylapatite / CaHA)

Radiesse is composed of calcium hydroxylapatite (CaHA) microspheres (25–45 microns in diameter) suspended in a water-based gel carrier containing glycerin, sodium carboxymethylcellulose, and sterile water. CaHA is a mineral compound naturally found in human bones and teeth.

FDA approval history:

• December 22, 2006 (PMA P050052): Approved for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.
• Radiesse is also FDA-approved for hand augmentation (approved June 2015), which remains unique among dermal fillers according to manufacturer Merz Aesthetics.

Mechanism: how they work differently

This is the most important distinction between the two products.

Sculptra — pure biostimulation

Sculptra provides minimal immediate volume (mostly transient swelling from the injected fluid). Its primary mechanism is biostimulation: the PLLA microparticles are phagocytosed by macrophages and fibroblasts, triggering a foreign-body response that stimulates new collagen deposition over weeks to months.

The process is gradual. PLLA microparticles remain active in tissue for an extended period, producing a cumulative collagen response that continues to build over the course of treatment.

Radiesse — immediate volume plus biostimulation

Radiesse works in two phases:

1. Immediate phase: The gel carrier provides instant volume and structural lift as soon as it is injected. This is visible right away.
2. Biostimulatory phase: The CaHA microspheres form a scaffold that stimulates fibroblasts to produce collagen type I, collagen type III, elastin, and proteoglycans. Over several months, the gel carrier is gradually absorbed while the new collagen replaces it.

This dual-action profile is why Radiesse is often described as a "hybrid" — it offers the instant gratification of a traditional filler with the longer-term collagen benefits of a biostimulator.

Side-by-side comparison

Ideal treatment areas

Sculptra

Sculptra is best suited for broad, diffuse volume restoration rather than precise contouring:

• Temples
• Lateral cheeks and mid-face
• Overall facial volume loss
• Off-label: buttocks ("Sculptra Butt Lift"), hip dips, chest, thighs

Because it works gradually and requires multiple sessions, Sculptra is not the right choice when a patient wants immediate correction or is treating an isolated deep fold.

Radiesse

Radiesse excels at structural support and contouring:

• Nasolabial folds and marionette lines
• Jawline definition
• Chin projection
• Cheek contouring (structural lift)
• Hand rejuvenation (FDA-approved)
• Off-label: non-surgical rhinoplasty (nose reshaping)

Hyperdiluted Radiesse

When Radiesse is diluted with saline or lidocaine beyond its standard concentration, it shifts from a volumizing filler to a biostimulatory skin treatment. Hyperdiluted Radiesse is used off-label for:

• Neck and chest (décolleté) skin quality
• Upper arm laxity
• Abdominal skin tightening

At higher dilutions, the immediate volume effect is minimal, and the focus is on collagen stimulation across wider, thinner skin areas. This application overlaps with some of Sculptra's use cases, but the onset is faster because even diluted CaHA begins stimulating collagen sooner.

Patient fit: who is each best for

Sculptra may be the better choice when:

• The primary concern is diffuse facial volume loss rather than a specific line or fold
• The patient is willing to wait months for gradual improvement and attend multiple sessions
• The goal is long-lasting results (up to 2+ years) with a natural evolution
• Treatment areas are broad: temples, cheeks, overall facial framework
• The patient is not seeking immediate correction for an upcoming event

Radiesse may be the better choice when:

• The patient wants immediate visible improvement
• The target area requires structural support: jawline, chin, deep nasolabial folds
• Fewer sessions are preferred
• Hand rejuvenation is the goal
• The treatment area is localized rather than diffuse

Neither is ideal when:

• The patient wants a reversible treatment. Neither Sculptra nor Radiesse can be dissolved with hyaluronidase. Once injected, the material must run its course. If reversibility is a priority, hyaluronic acid fillers are the safer option.
• The treatment area is the tear troughs, lips, or other delicate, mobile areas where precision and reversibility are paramount. Both products are generally too thick and too long-lasting for these zones.
• The patient has a history of keloid or hypertrophic scarring (both products list this as a contraindication in their FDA labeling).

Reversibility — the key limitation

Unlike hyaluronic acid fillers, which can be dissolved within hours using hyaluronidase, neither Sculptra nor Radiesse has a reversal agent. If a patient is unhappy with the result, or if a complication occurs (including vascular occlusion), management relies on:

• Waiting for natural resorption (months to years)
• Supportive treatments for complications
• Surgical intervention in extreme cases

This is why most experienced injectors recommend that patients new to fillers start with HA products before moving to biostimulators. If the patient tolerates HA fillers well and the injector understands their anatomy, biostimulators can then be considered for their longer-lasting, collagen-building benefits.

Side effects and risks

Common to both:

• Injection-site swelling, bruising, redness
• Tenderness at injection sites
• Temporary lumpiness (more common with Sculptra, which is why post-injection massage is required)

Sculptra-specific concerns:

• Late-onset papules and nodules. PLLA can form subcutaneous papules months to years after injection, sometimes visible around the eyes or mouth. The risk increases with superficial placement or insufficient reconstitution. The FDA labeling notes this risk.
• Delayed foreign-body reactions. Because PLLA remains active in tissue for extended periods, inflammatory responses can present late.

Radiesse-specific concerns:

• Vascular risk in danger zones. Radiesse's thicker consistency makes intravascular injection potentially more dangerous — the material can form obstructive emboli. This is particularly relevant in high-risk areas like the nose, glabella, and forehead.
• Visibility in thin skin. CaHA microspheres can occasionally be visible as a whitish discoloration under very thin skin, particularly if injected too superficially.

Cost comparison

Both products are more expensive per session than standard HA fillers, but the longevity and collagen-stimulating effects change the value calculus:

• Sculptra: $700–1,200 per vial. Most patients need 2–4 vials across 2–4 sessions. Total treatment cost typically ranges from $1,500–4,000 for a full facial series. Results can last up to 2+ years.
• Radiesse: $650–1,000 per syringe (1.5 mL). Most patients need 1–2 syringes for targeted areas. Total treatment cost typically ranges from $650–2,000. Results last 12–18 months.

Per-year cost tends to favor Sculptra for global facial treatment because its results last longer, while Radiesse may be more cost-effective for localized structural work that needs fewer sessions upfront.

Biostimulators and future surgery

A growing concern among plastic surgeons is that biostimulatory fillers — both Sculptra and Radiesse — can complicate future surgical procedures, particularly facelifts. Because these products stimulate collagen and fibrotic tissue that integrates with surrounding structures, surgical planes can become more difficult to dissect. Multiple dermatologists and plastic surgeons have noted that biostimulators injected into incorrect tissue layers pose the greatest risk of surgical complications down the line.

This does not mean biostimulators should be avoided. But patients who anticipate wanting a surgical facelift in the future should discuss this with their injector. Products placed in the correct anatomical plane (deep, along the periosteum or in the deep fat compartments) are less likely to interfere with future surgery than products injected diffusely into the superficial fat or subcutaneous tissue.

What to ask your provider

1. Which biostimulator are you recommending and why? The answer should reference your specific anatomy and goals, not just the product the practice stocks.
2. How many sessions do you estimate? If you have diffuse volume loss, a Sculptra series of 2–4 sessions is typical. If you need jawline definition, 1–2 Radiesse sessions may suffice.
3. Do you inject with needle or cannula? Cannulas reduce (but do not eliminate) the risk of intravascular injection.
4. What is your plan if there is a vascular complication? Your injector should have hyaluronidase on hand and a clear emergency protocol, even though it cannot dissolve Sculptra or Radiesse. Supportive measures, nitroglycerin paste, and emergency referral protocols still apply.
5. Have you treated patients with similar anatomy and concerns with this product? Biostimulators require more planning than HA fillers because they are not reversible. Experience matters more here than with HA.

Sources

• U.S. FDA. "Sculptra — P030050/S039." April 25, 2023. https://www.fda.gov/medical-devices/recently-approved-devices/sculptra-p030050s039
• U.S. FDA. "Summary of Safety and Effectiveness Data: Sculptra Aesthetic (P030050/S002)." https://www.accessdata.fda.gov/cdrh_docs/pdf3/p030050s002b.pdf
• U.S. FDA. "Summary of Safety and Effectiveness Data: RADIESSE (P050052)." https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050052b.pdf
• StatPearls, NCBI Bookshelf. "Poly-L-Lactic Acid." National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK507871/
• Drugs.com. "Sculptra FDA Approval History." https://www.drugs.com/history/sculptra.html
• American Board of Cosmetic Surgery. "Sculptra Receives FDA Approval for Cheek Wrinkles." https://www.americanboardcosmeticsurgery.org/blog/sculptra-receives-fda-approval-for-cheek-wrinkles/
• JMIR Dermatology. "Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations." 2024. https://derma.jmir.org/2024/1/e50403